HOME >> MEDICINE >> NEWS
Drug-eluting stent controversy explored in the American Heart Hospital Journal

Shelton, Conn. - August 08, 2007 The Summer 2007 issue of The American Heart Hospital Journal explores one of the pivotal issues in cardiology today, the drug-eluting stent (DES). Through commentaries from ten leading national and international specialists, the issue presents a comprehensive discussion on the explosive growth and the potential risks of DESs.

The issue reports on the initial enthusiasm for drug-eluting stents, the great advances made possible by their use, and explores the significance of the benefits and disadvantages revealed through their high-volume adoption.

Dr. Ulrich Sigwart of University Hospital in Geneva, Switzerland, author of one of the studies, examines the sobering current appraisal of DES use, in contrast to the triumphs of their early success. Subacute stent thrombosis due to incomplete intimal coverage, the formation of blood clots that can occur when the inner layers of blood vessels are not fully treated, remains the Achilles heel of DES use, says Dr. Sigwart. The polymer matrix used for the delivery of drugs, which clearly induces inflammatory responses, may, in part, be responsible for very late thrombosis.

Dr. Renu Virmani and colleagues at the CVPath Institute of Gaithersburg, Maryland base the judgments in their article on the evidence obtained through pathologic studies of patients dying after stent implantation. These data indicate that DESs cause both substantial impairment in arterial healing characterized by lack of complete re-endothlialization (the re-healing of the inner surfaces of vessels after stenting) and persistence of fibrin, a protein that indicates blood clotting, when compared with bare metal stents. This delayed healing is the primary substrate underlying all cases of late DES thrombosis at autopsy.

In contrast, Drs. Williams and Abbott, of Brown Medical School and affiliated with Rhode Island Hospital, note, DESs are a revolutionary advancement in interventional
'"/>

Contact: Sean Wagner
swagner@bos.blackwellpublishing.com
781-388-8550
Blackwell Publishing Ltd.
8-Aug-2007


Page: 1 2

Related medicine news :

1. Drug-eluting and absorbable stents push interventional frontiers
2. Drug-eluting stents outperform radiation treatment for coronary restenosis in bare metal stents
3. Drug-eluting stents may cause allergic reactions
4. Drug-eluting stents successfully treat vein-graft disease
5. SCAI news: Drug-eluting stents prove mettle in heart attack patients
6. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
7. New study counts the economic cost of persistent pain in Australia
8. New biodegradable magnesium stents for coronary arteries
9. Emory University researchers find persistent and severe asthma associated with obesity
10. Persistent smokers may have higher risk to become depressed than never smokers
11. Long-term anti-clotting therapy sweetens stenting outcomes in diabetic patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/16/2019)... , ... August 16, 2019 , ... ... and standardize pharmaceutical and non-pharmaceutical cannabidiol (CBD) products across the CBD market in ... to launch its crowdfunding campaign to raise $50 million on September 9, 2019. ...
(Date:8/16/2019)... PARK, N.Y. (PRWEB) , ... August 16, 2019 ... ... fabricated, and donated a custom handcrafted, one-of-a-kind children’s aircraft to Ronald McDonald House ... was designed to give children residents undergoing medical treatments and their family members ...
(Date:8/16/2019)... ... August 16, 2019 , ... Dr. Demetri Arnaoutakis, ... esteemed Haute Beauty Network. , The Haute Beauty Network, well known for its ... as a hair restoration expert and our newest addition to the Haute Beauty ...
(Date:8/15/2019)... ... 2019 , ... The ASCP Foundation has launched a campaign ... the closure of Hahnemann University Hospital in Philadelphia, which is affiliated with Drexel ... will be making hardship grants of up to $2,500 per resident available to ...
(Date:8/15/2019)... ... August 15, 2019 , ... Jon O'Brien, ... for family planning clinics to provide written assurance that they will comply with ... to the Global Gag Rule, the new policy restricts providers and clinics that ...
Breaking Medicine News(10 mins):
(Date:8/12/2019)... ... August 12, 2019 , ... Intalere, the healthcare industry leader ... as a finalist in the Innovator of The Year - Health IT category of ... be recognized by the Pittsburgh Technology Center as a healthcare IT innovator in the ...
(Date:8/10/2019)... SAN LUIS OBISPO, Calif. (PRWEB) , ... August 10, 2019 , ... ... parents should worry too much about up to 4 years of age, but past ... Perry Patel has recently released a report to help parents know when to intervene ...
(Date:8/9/2019)... Ariz. (PRWEB) , ... August 09, 2019 , ... ... Dr. Austin Cope earned a bachelor’s degree in biology from Dixie State University in ... Texas Tech University and a doctor of medicine from Texas Tech University Health Sciences ...
Breaking Medicine Technology:
Cached News: